Abstract
Background: Misuse and abuse of prescription drugs in the child and adolescent population is a growing health problem that can have devastating consequences. Bupropion is an antidepressant approved for the treatment of depression and smoking cessation in adults; however, it is also used off-label as mono- or adjunct therapy in children and adolescents for the treatment of depression and attention-deficit hyperactivity disorder (ADHD). Like other prescription drugs, bupropion has also shown abuse potential, but there are concerns for decreased seizure threshold as an adverse effect. Seizures in the context of recreational abuse have been reported in adults but little is known about this phenomenon in adolescents.
Method: We report three cases of adolescents who presented to a tertiary medical center with seizures in the context of a history of recreational abuse of bupropion. We review the intended use of bupropion and the potential for abuse, as well as the side effect profile for providers in consideration of its use in adolescents.
Conclusions: There is a potential for seizures in the use/misuse/abuse of bupropion. Prescribing health providers should warn all patients of this adverse effect and also query history of substance use prior to prescribing bupropion.
Keywords: Adolescent, bupropion, prescription medications, prevention, seizures, substance abuse.
Adolescent Psychiatry
Title:Seizures Secondary to Bupropion Misuse/Abuse: Three Cases
Volume: 3 Issue: 2
Author(s): Sabreen Rahman, Sarah Mohiuddin and Liwei L. Hua
Affiliation:
Keywords: Adolescent, bupropion, prescription medications, prevention, seizures, substance abuse.
Abstract: Background: Misuse and abuse of prescription drugs in the child and adolescent population is a growing health problem that can have devastating consequences. Bupropion is an antidepressant approved for the treatment of depression and smoking cessation in adults; however, it is also used off-label as mono- or adjunct therapy in children and adolescents for the treatment of depression and attention-deficit hyperactivity disorder (ADHD). Like other prescription drugs, bupropion has also shown abuse potential, but there are concerns for decreased seizure threshold as an adverse effect. Seizures in the context of recreational abuse have been reported in adults but little is known about this phenomenon in adolescents.
Method: We report three cases of adolescents who presented to a tertiary medical center with seizures in the context of a history of recreational abuse of bupropion. We review the intended use of bupropion and the potential for abuse, as well as the side effect profile for providers in consideration of its use in adolescents.
Conclusions: There is a potential for seizures in the use/misuse/abuse of bupropion. Prescribing health providers should warn all patients of this adverse effect and also query history of substance use prior to prescribing bupropion.
Export Options
About this article
Cite this article as:
Rahman Sabreen, Mohiuddin Sarah and L. Hua Liwei, Seizures Secondary to Bupropion Misuse/Abuse: Three Cases, Adolescent Psychiatry 2013; 3 (2) . https://dx.doi.org/10.2174/2210676611303020013
DOI https://dx.doi.org/10.2174/2210676611303020013 |
Print ISSN 2210-6766 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-6774 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cardiovascular Biology of Interleukin-6
Current Pharmaceutical Design Emerging Therapies for Type 2 Diabetes
Current Drug Therapy Transporters at CNS Barrier Sites: Obstacles or Opportunities for Drug Delivery?
Current Pharmaceutical Design Editorial (Thematic Issue: The Crosstalk between Non-Pharmaceutical and Pharmaceutical Approaches to Prevention and Treatment of Chronic Diseases: Current Concepts and Perspectives)
Current Pharmaceutical Design Platelets and Platelet Interaction with Progenitor Cells in Vascular Homeostasis and Inflammation
Current Vascular Pharmacology Management of the Metabolic Syndrome as a Strategy for Preventing the Macrovascular Complications of Type 2 Diabetes: Controversial Issues
Current Diabetes Reviews Bioinformatics Study on Serum Triglyceride Levels for Analysis of a Potential Risk Factor Affecting Blood Pressure Variability
Current Bioinformatics Genetic Variant-Associated Endothelial Dysfunction Behind Small-Vessel Cerebral Circulatory Disorders: A New Pathomechanism Behind Common Cerebral Phenotypes
Mini-Reviews in Medicinal Chemistry Prostaglandin E2: From Clinical Applications to Its Potential Role in Bone- Muscle Crosstalk and Myogenic Differentiation
Recent Patents on Biotechnology Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Main Text
Current Vascular Pharmacology From Anti-allergic to Anti-Alzheimer ’ s: Molecular Pharmacology of Dimebon™
Current Alzheimer Research Semi-Quantitative Ultrasonographic Evaluation of NAFLD
Current Pharmaceutical Design Stress, Cardiovascular Diseases and Surgery-Induced Angiogenesis
Current Angiogenesis (Discontinued) The Role of Oxidative Stress in the Pathogenesis of Type 2 Diabetes Mellitus Micro- and Macrovascular Complications: Avenues for a Mechanistic-Based Therapeutic Approach
Current Diabetes Reviews Circulating and Vascular Bioactive Factors During Hypertension in Pregnancy
Current Bioactive Compounds Targeting CSCs in Tumor Microenvironment: The Potential Role of ROS-Associated miRNAs in Tumor Aggressiveness
Current Stem Cell Research & Therapy A Review of Diabetes Mellitus and Exposure to the Environmental Toxicant Cadmium with an Emphasis on Likely Mechanisms of Action
Current Diabetes Reviews Piroxicam: Source for Synthesis of Central Nervous System (CNS) Acting Drugs
Central Nervous System Agents in Medicinal Chemistry Diagnostics and Therapy of Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitides
Current Pharmaceutical Design Is It Possible to Apply Secondary Stroke Prevention Guidelines to Very Old Populations?
Cardiovascular & Hematological Disorders-Drug Targets